HDAC inhibitors suppress the proliferation, migration, and invasiveness of head and neck squamous cell carcinoma (HNSCC) by down-regulating the p63-mediated tight junction molecules JAM-A and claudin-1 [148]. This evidence concerns the gene HDAC9 and head and neck squamous cell carcinoma.